UCSF’s Division of Cardiology to Partner with Rosenman Institute
the UCSF Rosenman Institute BUILD™ Heart Health program, in collaboration with the American Heart Association, aims to train the next generation of health technology entrepreneurs.
University of California San Francisco
Give to UCSFthe UCSF Rosenman Institute BUILD™ Heart Health program, in collaboration with the American Heart Association, aims to train the next generation of health technology entrepreneurs.
UCSF interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.
UCSF’s Heart and Vascular Center participation in a new Cardiogenic Shock Registry aims to improve treatment for cardiogenic shock types.
Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.
A UCSF study finds increase in percutaneous coronary intervention (PCI) at low-volume hospitals over time for all races, insurance types and incomes.
UCSF surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.
Promises from companies leap ahead of medical science in promoting the use of smartwatches to screen for heart rhythm disorders says UCSF’s Gregory Marcus.
To improve assessment of patients who may be at risk for aortic dissection and rupture, researchers from UCSF researchers developed a prediction model of aortic diameter to identify asymptomatic individuals with enlarged ascending aortic diameter.
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UCSF.
Immune checkpoint inhibitors (ICIs) used in cancer care can cause myocarditis, a potentially fatal side effect, and it appears that the adverse cardiac effects may disproportionally impact female patients.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.